NCT04110938

Brief Summary

In the UK, critical illness or injury affects about 19,000 Children and Young Persons (CYP) every year who are admitted to the paediatric intensive care unit (PICU) to receive life-sustaining treatments. Although survival rates from PICU are at an all-time high (\>96%), low levels of mortality have been offset by an increase in morbidity. The impact of being critically ill and exposed to the PICU is multiple. Weakness, cognitive impairment, organ dysfunction, and psychological problems have been reported to emanate from deconditioning. Subsequently, post-PICU many CYP experience significant and residual physical, cognitive, and psychosocial morbidities that impact on their quality of life. The contemporary focus has turned to the development, testing, and implementation of interventions to minimize the harmful effects of critical care and maximize patient outcomes. Early rehabilitation and/or mobilisation (ERM) encompasses patient-tailored interventions, delivered individually or in a bundled package, provided by health professionals from multiple disciplines and care-givers within intensive care settings to promote recovery, both physical (e.g. movement, functional activities, ambulation) and non-physical (e.g. speech, play, psychological, cognitive). Rehabilitation has been shown to improve quality of life and patient outcomes; reduce health inequalities, and make significant savings to the health care system. Benefits have been demonstrated in the use of ERM in adult ICU populations in relation to patient outcomes as well as healthcare utilization. Studies also indicate that the intervention is safe and feasible, reduces delirium and increases ventilator-free days, improves day-to-day functioning and reduces hospital readmissions. However, in the United Kingdom (UK), the understanding of current ERM practices (including content, barriers, facilitators, feasibility, and safety) and their impact on the outcomes of pediatric ICU patients is limited. This has stifled an evidence-based approach to ERM which has resulted in disparity in the adoption and utilization of ERM interventions in PICUs across the UK. To address this critical gap, the first phase of a four-phase program of the PERMIT study will generate evidence of current PICU ERM practices by conducting a survey and an observational study. The second phase of the study will involve conducting qualitative workshops to develop a prototype ERM program. Qualitative workshops will also be conducted among key stakeholders (clinicians, parents, CYP) to inform the design of an ERM intervention. The third phase will investigate this ERM program in a pilot study in UK PICUs and finally, the efficacy of the intervention will be tested using a large scale, definitive randomized controlled trial (RCT).

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
150

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Oct 2019

Shorter than P25 for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

August 14, 2019

Completed
2 months until next milestone

First Posted

Study publicly available on registry

October 1, 2019

Completed
27 days until next milestone

Study Start

First participant enrolled

October 28, 2019

Completed
1 month until next milestone

Primary Completion

Last participant's last visit for primary outcome

November 30, 2019

Completed
11 months until next milestone

Study Completion

Last participant's last visit for all outcomes

October 31, 2020

Completed
Last Updated

October 1, 2019

Status Verified

August 1, 2019

Enrollment Period

1 month

First QC Date

August 14, 2019

Last Update Submit

September 30, 2019

Conditions

Keywords

PICUPaediatricEarly mobilisationEarly rehabilitationObservational

Outcome Measures

Primary Outcomes (1)

  • Number of early rehabilitation and/or mobilisation (ERM) delivered on Day 3 post PICU admission

    The prevalence and scope of ERM will be described as the proportion of patients with any 'active interaction' delivered on Day 3 post-admission.

    3 weeks

Secondary Outcomes (5)

  • Incidence rates and ratios of the number of ERM interventions from Day 3 to Day 10 post PICU admission

    3 weeks

  • The cumulative prevalence of ERM for each day in PICU after Day 3 up to Day 10 post-admission

    3 weeks

  • Factors associated with variability of early rehabilitation and/or mobilisation (ERM) delivery

    3 weeks

  • To evaluate predictors of ERM provided on Day 3 post-PICU-admission

    3 weeks

  • Dose of ERM per day of PICU admission

    3 weeks

Eligibility Criteria

Age38 Weeks - 16 Years
Sexall
Age GroupsChild (0-17)
Sampling MethodNon-Probability Sample
Study Population

All Children and Young Persons (CYP) (0-\<16 years) admitted to paediatric itnesive care units for 3 days or more

You may qualify if:

  • All Children and Young Persons (CYP) (0-\<16 years)
  • Admitted to PICU
  • Remain within PICU on day 3 post-admission

You may not qualify if:

  • Local decision by PI or treating clinical team not to include patient
  • Parent or guardian choose to opt out.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Birmingham Women's and Children's Hospital PICU

Birmingham, West Midlands, B4 6NH, United Kingdom

Location

Related Publications (1)

  • Scholefield BR, Menzies JC, McAnuff J, Thompson JY, Manning JC, Feltbower RG, Geary M, Lockley S, Morris KP, Moore D, Pathan N, Kirkham F, Forsyth R, Rapley T. Implementing early rehabilitation and mobilisation for children in UK paediatric intensive care units: the PERMIT feasibility study. Health Technol Assess. 2023 Nov;27(27):1-155. doi: 10.3310/HYRW5688.

MeSH Terms

Conditions

Critical Illness

Condition Hierarchy (Ancestors)

Disease AttributesPathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Barnaby Scholefield, Dr

    Birmingham Women's and Children's Hospital

    STUDY CHAIR

Central Study Contacts

Barnaby Scholefield, Dr

CONTACT

Jacqueline Thompson, MPH

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
PROSPECTIVE
Target Duration
3 Weeks
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 14, 2019

First Posted

October 1, 2019

Study Start

October 28, 2019

Primary Completion

November 30, 2019

Study Completion

October 31, 2020

Last Updated

October 1, 2019

Record last verified: 2019-08

Locations